The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl
Abstract
The p210(bcr-abl) and p190(bcr-abl) fusion proteins, respectively responsible for chronic myelogenous leukemia and acute lymphoblastic leukemia, present deregulated tyrosine kinase activity and abnormal localization. The Dbl homology domain of Bcr, activating Rho GTPases, is present in p210(bcr-abl), but absent in p190(bcr-abl). We investigated the interaction of Bcr-Abl chimeras and Rho proteins by coimmunoprecipitation, pull-down experiments and GEF activity measurement. RhoA, Rac1 and Cdc42 interact in vivo with p210(bcr-abl) only. Moreover, the three types of GTPases are activated in vitro and in vivo by p210(bcr-abl). Nevertheless, Rac1 and Cdc42, but not RhoA, are activated by p190(bcr-abl) in vitro and in vivo. Part of this GEF activity of p190(bcr-abl) is probably attributable to p95(vav), which is complexed with both p190(bcr-abl) and p210(bcr-abl) in an activated form. p160(bcr), also in complex with Bcr-Abl, presents no GEF activity in p190(bcr-abl)-expressing cells. These results suggest that differential activation of Rho proteins should play a major role in Bcr-Abl-induced leukemogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p190-BCR-ABL, which lacks this domain, cannot bind to Rho GTPases but can still activate Rac1 and Cdc42 (Harnois et al., 2003) through activation of the guanine exchange factor (GEF) Vav1 by BCR-ABL (Bassermann et al., 2002).”
From Rac Guanosine Triphosphatases Represent Integrating Molecular Therapeutic Targets for BCR-ABL-Induced Myeloproliferative Disease (2007) · cites this paper as Harnois et al., 2003
In the citing paper
“while p210-BCR-ABL binds to and activates the Rho GTPases, apparently through the Dbl homology domain”
From Rac Guanosine Triphosphatases Represent Integrating Molecular Therapeutic Targets for BCR-ABL-Induced Myeloproliferative Disease (2007) · cites this paper as Harnois et al., 2003
Citations
Cites
Rho family proteins and Ras transformation: the RHOad less traveled gets congested
Zohn, I. M., Campbell, S. L., Khosravi-Far, R., Rossman, K. L., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202181 · Cited by 352
Research works printed but not linked: 50
- Adamson P, Paterson HF and Hall A . (1992). J. Cell Biol., 119, 617–627. · DOI
- Aghazadeh B, Lowry WE, Huang X-Y and Rosen MK . (2000). Cell., 102, 625–633. · DOI
- Bassermann F, Jahn T, Miething C, Seipel P, Bai RY, Coutinho S, Tybulewicz VL, Peschel C and Duyster J . (2002). J. Biol. Chem., 277, 12437–12445. · DOI · Paper page
- Bazzoni G, Carlesso N, Griffin JD and Hemler ME . (1996). J. Clin. Invest., 98, 521–528. · DOI
- Burstein ES, Hesterberg DJ, Gutkind JS, Brann MR, Currier EA and Messier TL . (1998). Oncogene, 17, 1617–1623. · DOI
- Chuang T-H, Xu X, Kaartinen V, Heisterkamp N, Groffen J and Bokoch G . (1995). Proc. Natl. Acad. Sci. USA, 92, 10282–10286. · DOI
- Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist G, Rovera W, Smith SD and Witte ON . (1988). Science, 239, 775–777. · DOI
- Daley GQ and Baltimore D . (1988). Proc. Natl. Acad. Sci. USA, 85, 9312–9316. · DOI
- Daley GQ, Van Etten RA and Baltimore D . (1990). Science, 247, 824–830. · DOI · Paper page
- Das B, Shu X, Day GJ, Han J, Krishna UM, Falck JR and Broeck D . (2000). J. Biol. Chem., 275, 15074–15081. · DOI
- Druker B, Okuda K, Matulonis U, Salgia R, Roberts T and Griffin JD . (1992). Blood, 79, 2215–2220. · DOI
- Eda M, Yonemura S, Kato T, Watanabe N, Ishizaki T, Madaule P and Narumiya S . (2001). J. Cell Sci., 114, 3273–3284. · DOI
- Han J, Das B, Wie W, Van Aelst L, Mosteller RD, Kosravi-Far R, Westwick JK, Der CJ and Broeck D . (1997). Mol. Cell. Biol., 17, 1346–1353. · DOI
- Hansen MD and Nelson WJ . (2001). Curr. Biol., 11, 356–360. · DOI
- Hart M, Eva A, Evans T, Aaronson SA and Cerione RA . (1991). Nature, 354, 311–315. · DOI
- Hoshino M, Sone M, Fukata M, Kuroda S, Kaibuchi K, Nabeshima Y and Hama C . (1999). J. Biol. Chem., 274, 17837–17844. · DOI
- Ilaria Jr RL and Van Etten RA . (1996). J. Biol. Chem., 271, 31704–31710. · DOI
- Laëmmli UK and Favre M . (1973). J. Mol. Biol., 80, 575–599. · DOI
- Li S, Ilaria Jr RL, Million RP, Daley GQ and Van Etten RA . (1999). J. Exp. Med., 189, 1399–1412. · DOI
- Lipp é R, Miaczynska M, Rybin V, Runge A and Zerial M . (2001). Mol. Biol. Cell., 12, 2219–2228. · DOI
- Lugo TG, Pendergast A-M, Muller AJ and Witte ON . (1990). Science, 247, 1079–1082. · DOI
- Matsuguchi T, Inborn RC, Carlesso N, Xu G, Druker B and Griffin JD . (1995). EMBO J., 14, 257–265. · DOI
- McWhirter JR, Gallasso DL and Wang JYJ . (1993). Mol. Cell. Biol., 13, 7587–7595. · DOI
- McWhirter JR and Wang JYJ . (1993). EMBO J., 12, 1533–1546. · DOI
- Missy K, Van Poucke V, Raynal P, Viala C, Mauco G, Plantavid M, Chap H and Payrastre B . (1998). J. Biol. Chem., 273, 30279–30286. · DOI
- Nakashima S and Nozawa Y . (1999). Chem. Phys. Lipids, 98, 153–164. · DOI
- Nishida K, Kaziro Y and Satoh T . (1999). Oncogene, 18, 407–415. · DOI
- Nobes CD and Hall A . (1999). J. Cell Biol., 144, 1235–1244. · DOI
- Ohguchi K, Nakashima S, Tan Z, Banno Y, Dohi S and Nozawa Y . (1997). J. Biol. Chem., 272, 1990–1996. · DOI
- Olson MF, Pasteris NG, Gorski JL and Hall A . (1996). Curr. Biol., 6, 1628–1633. · DOI
- Olson MF, Paterson HF and Marshall CJ . (1998). Nature, 394, 295–298. · DOI
- Pear W, Nolan GP, Scott ML and Baltimore D . (1993). Proc. Natl. Acad. Sci. USA, 90, 8392–8396. · DOI
- Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R and Pawson T . (1994). EMBO J., 13, 764–773. · DOI
- Qiu R-G, Chen J, Kirn D, McCormick F and Symons M . (1995). Nature, 374, 457–459. · DOI
- Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS and Pendergast AM . (2000). Blood, 95, 2913–2921. · DOI
- Roig J, Tuazon PT, Zipfel PA, Pendergast AM and Traugh JA . (2000). Proc. Natl. Acad. Sci. USA, 97, 14346–14351. · DOI
- Rudolph MG, Linnemann T, Grunewald P, Wittinghofer A, Vetter IR and Herrmann C . (2001). J. Biol. Chem., 276, 23914–23921. · DOI
- Salgia R, Li J-L, Ewaniuk DS, Pear W, Pisick E, Burky SA, Ernst T, Sattler M, Chen LB and Griffin JD . (1997). J. Clin. Invest., 100, 46–57. · DOI · Paper page
- Sander EE, ten Klooster JP, van Delft S, van der Kammen RA and Collard JG . (1999). J. Cell Biol., 147, 1009–1021. · DOI
- Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F and Collard JG . (1998). J. Cell Biol., 143, 1385–1398. · DOI
- Skorski T, Kanakaraj P, Nieborowska-skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B and Calabretta B . (1995). Blood, 86, 726–736. · DOI
- Skorski T, Wlodarski P, Daheron L, Salomon P, Nieborowska-Skorska M, Majewski M, Wazik M and Calabretta B . (1998). Proc. Natl. Acad. Sci. USA, 95, 11858–11862. · DOI · Paper page
- Skourides PA, Perera SA and Ren R . (1999). Oncogene, 18, 1165–1176. · DOI
- Tapon N and Hall A . (1997). Curr. Opin. Cell Biol., 9, 86–92. · DOI
- Tolias KF, Cantley LC and Carpenter CL . (1995). J. Biol. Chem., 270, 17656–17659. · DOI
- Van Etten RA . (1999). Trends Cell Biol., 9, 179–186. · DOI
- Verfaillie CM, Hurley R, Lundell BI, Zao C and Bahtia R . (1995). Acta Haematol., 97, 40–52. · DOI
- Voncken JW, van Shaick H, Kaartinen V, Deemer K, Coates T, Landing B, Pattengale P, Dorseuil O, Bokoch GM, Groffen J and Heisterkamp N . (1995). Cell, 80, 719–728. · DOI
- Wu Y, Ma G, Lu D, Lin F, Xu HJ, Liu J and Arlinghaus RB . (1999). Oncogene, 18, 4416–4424. · DOI
- Zhu X, Boman AL, Kuai J, Ciepak W and Kahn RA . (2000). J. Biol. Chem., 275, 13465–13475. · DOI
Cited by
Thomas, E. K., Cancelas, J. A., Chae, H.-D., Cox, A. D., Keller, P. J., Perrotti, D., Neviani, P., Druker, B. J., Setchell, K. D. R., Zheng, Y., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.015 · Cited by 147
Metadata
- Authors
- Harnois, T., Constantin, B., Rioux, A., Grenioux, E., Kitzis, A., & Bourmeyster, N.
- Venue
- Oncogene
- Published
- 2003-09-25
- Volume
- 22
- Issue
- 41
- Pages
- 6445-6454
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 58
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl. https://app.cochat.ai/papers/10.1038/sj.onc.1206626
- The paper
- Harnois, T., Constantin, B., Rioux, A., Grenioux, E., Kitzis, A., & Bourmeyster, N. (2003). Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl. Oncogene. https://doi.org/10.1038/sj.onc.1206626